Fundz

Rockcliffe Labs secures $75 million in a private placement, reflecting a $300 million post-money valuation and licenses a sepsis biomarker program from a Canadian university.

PRIVATEOct 02, 2025

Amount Raised

C$75 Million

Round Type

Post-IPO Equity

MontrealManufacturingBiotechnology

Description

Rockcliffe Labs Inc. announces the launch of a $75 million non-brokered private placement in Canada at $10 per share. The offering reflects a post-money valuation of approximately $300 million. The Canadian university will hold a 7.5% equity interest in Rockcliffe Labs

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Rockcliffe Labs that raised within 45 days of this round, from Fundz verified event records.

  • PeptiSystems raised an undisclosed amount (Private Equity) on November 13, 2025.
  • HRS Navigation raised $5M (Pre-Series A) on November 12, 2025.
  • Lineage Cell Therapeutics raised $21M (Funding Round) on November 12, 2025.
  • Tenon Medical raised $2.9M (Funding Round) on November 11, 2025.
  • Qorium raised $25M (Series A) on November 11, 2025.
  • Allurion Technologies raised $5M (Private Equity) on November 11, 2025.

Who to call at Rockcliffe Labs, and when

A new round usually means Rockcliffe Labs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rockcliffe Labs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rockcliffe Labs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rockcliffe Labs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rockcliffe Labs

Location

Montreal, Quebec, Canada

About

Rockcliffe Labs Inc. is a Canadian biotechnology platform that creates ventures at the intersection of academic discovery and capital markets execution. By licensing breakthrough technologies from leading Canadian research institutions and providing the clinical, regulatory, and commercial frameworks to advance them, Rockcliffe Labs develops multi-asset pipelines across pharmaceuticals, diagnostics, and bio-based technologies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rockcliffe Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Rockcliffe Labs's next move

See what Strategic adds

Rockcliffe Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.